A detailed history of Optivise Advisory Services LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Optivise Advisory Services LLC holds 2,465 shares of MRK stock, worth $242,457. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,465
Holding current value
$242,457
% of portfolio
0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$111.15 - $128.97 $273,984 - $317,911
2,465 New
2,465 $280 Million
Q2 2024

Nov 14, 2024

SELL
$123.8 - $132.96 $9,408 - $10,104
-76 Reduced 3.08%
2,389 $296 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Optivise Advisory Services LLC Portfolio

Follow Optivise Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optivise Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Optivise Advisory Services LLC with notifications on news.